Data / Form D filings / DalCor Pharmaceuticals US, LLC
DalCor Pharmaceuticals US, LLC: Form D filings
DalCor Pharmaceuticals US, LLC, a pharmaceuticals company in Sarasota, FL, filed 5 Form D notices with the SEC between 2016 and 2026. The latest, on August 28, 2026, reports $7 million sold of a $7 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 677 North Washington Blvd Suite 132, Sarasota, FL, 34236
- Phone
- (514) 508-5099
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1673368
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | New notice | $6,958,236 | $6,958,236 | 8 | Jul 30, 2026 | sec.gov | |
| Sep 14, 2020 | Amendment | $3,851,699 | $3,851,699 | 4 | May 12, 2020 | sec.gov | |
| May 27, 2020 | New notice | $2,845,541 | $1,336,304 | $1,509,237 | 4 | May 12, 2020 | sec.gov |
| May 12, 2017 | Amendment | $110,000,000 | $55,000,000 | $55,000,000 | 47 | Apr 29, 2016 | sec.gov |
| May 13, 2016 | New notice | $110,000,000 | $16,500,000 | $93,500,000 | 44 | Apr 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas Michael Dixon | Director | |
| Paul Fonteyne | Director |
Every Form D from the week of Aug 24, 2026 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DalCor Pharmaceuticals US, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.